Tag: cancer-supportive-care
New NEJM Trial Shows Romiplostim Reduces Chemotherapy-Induced Thrombocytopenia Risk
A randomized controlled trial in NEJM shows romiplostim significantly reduces chemotherapy-induced thrombocytopenia compared to placebo. The findings could transform cancer…
Submit Your Paper to GMJ
No APC until January 2027.